← Leaderboards
Oliver Graudejus
Bmseed, Llc
$5,425,899
Attributed
$5,425,899
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $861.3K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,425,899 · 5
By mechanism
R44$3,767,477 · 2
R43$1,658,422 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Evaluation”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- David Heimbrook · Leidos Biomedical Research, Inc.$564,050,020
- Lawrence Corey · Fred Hutchinson Cancer Center$559,122,174
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$489,869,793
- Jeffrey P Krischer · University Of South Florida$466,087,841
- Judith S. Currier · University Of California Los Angeles$403,175,569
Research focus
EvaluationIn VivoStretchingMicroelectrodesAlzheimer&AposTraumatic Brain InjuryRelating To Nervous SystemIn VitroElectrophysiology (Science)AnimalsTechnologyElectrodesPre-ClinicalBrainMechanicsCommercializationPrototypeCellsBiomechanicsLaboratory ResearchData AcquisitionCostEnvironmentBase
Grant awards (15)
A physiologically relevant pre-clinical drug screening platform for Alzheimer's Disease and Traumatic Brain Injury with integrated stretchable microelectrodes$779,587
R44 · FY2025 · AG · contact PI
A physiologically relevant pre-clinical drug screening platform for Alzheimer's Disease and Traumatic Brain Injury with integrated stretchable microelectrodes$861,339
R44 · FY2024 · AG · contact PI
A physiologically relevant pre-clinical drug screening platform for Alzheimer's Disease and Traumatic Brain Injury with integrated stretchable microelectrodes$449,997
R44 · FY2022 · AG · contact PI
The first adaptable, 3D-formfitting microelectrode array for organoid-based models of neurological and neurodegenerative diseases$55,000
R43 · FY2022 · NS · contact PI
The first adaptable, 3D-formfitting microelectrode array for organoid-based models of neurological and neurodegenerative diseases$419,641
R43 · FY2021 · NS · contact PI
Lab-To-Marketplace: Commercialization of a stretchable microelectrode array$95,200
R44 · FY2020 · NS · contact PI
Lab-To-Marketplace: Commercialization of a stretchable microelectrode array$95,200
R44 · FY2020 · NS · contact PI
Lab-To-Marketplace: Commercialization of a stretchable microelectrode array$689,298
R44 · FY2019 · NS · contact PI
Lab-To-Marketplace: Commercialization of a stretchable microelectrode array$796,856
R44 · FY2018 · NS · contact PI
Development of a large area high resolution micro ECoG electrode array$189,443
R43 · FY2017 · NS · contact PI
Development of a large area high resolution micro ECoG electrode array$49,999
R43 · FY2017 · NS · contact PI
Development of a large area high resolution micro ECoG electrode array$329,540
R43 · FY2016 · NS · contact PI
Lab-To-Marketplace: Commercialization of a stretchable microelectrode array$201,226
R43 · FY2015 · NS · contact PI
Lab-To-Marketplace: Commercialization of a stretchable microelectrode array$25,000
R43 · FY2015 · NS · contact PI
Lab-To-Marketplace: Commercialization of a stretchable microelectrode array$388,573
R43 · FY2014 · NS · contact PI